Skip to main content
NCBI home page
British Journal of Industrial Medicine logoLink to British Journal of Industrial Medicine
. 1983 Aug;40(3):280–284. doi: 10.1136/oem.40.3.280

Effects of chronic exposure to arsenate on the cardiovascular function of rats.

M Carmignani, P Boscolo, A Iannaccone
PMCID: PMC1069323  PMID: 6871116

Abstract

Cardiovascular function was studied in anaesthetised male rats which received 50 micrograms/ml of arsenic (as sodium arsenate) in deionised drinking water for 320 days. High urinary excretion of arsenic was found at the end of treatment and the metal accumulated considerably in the kidneys and liver, which both presented slight alterations. No histopathological modifications were evident in other organs. Base line blood pressure, cardiac inotropism, and chronotropism and cardiovascular reactivity to noradrenaline, acetylcholine, angiotensin II, bradykinin, histamine, and serotonin did not differ in exposed or in control animals. In the exposed group, however, there was potentiation of the effects of vascular beta-adrenoceptor stimulation and a reduction in the vascular responsiveness to angiotensin I. Chronic arsenic exposure did not affect the baroreflex sensitivity but was able to induce sympathetic hyperactivity or hypersensitivity, or both, possibly associated with an antivagal action. Our results might help to explain the cardiovascular alterations seen in people chronically exposed to high concentrations of arsenic.

Full text

PDF
280

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelson O., Dahlgren E., Jansson C. D., Rehnlund S. O. Arsenic exposure and mortality: a case-referent study from a Swedish copper smelter. Br J Ind Med. 1978 Feb;35(1):8–15. doi: 10.1136/oem.35.1.8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Borgoño J. M., Greiber R. Estudio epidemiológico del arsenicismo en la ciudad de Antofagasta. Rev Med Chil. 1971 Sep;99(9):702–707. [PubMed] [Google Scholar]
  3. Byron W. R., Bierbower G. W., Brouwer J. B., Hansen W. H. Pathologic changes in rats and dogs from two-year feeding of sodium arsenite or sodium arsenate. Toxicol Appl Pharmacol. 1967 Jan;10(1):132–147. doi: 10.1016/0041-008x(67)90135-4. [DOI] [PubMed] [Google Scholar]
  4. Davidson D. M., Covell J. W., Malloch C. I., Ross J., Jr Factors influencing indices of left ventricle contractility in the conscious dog. Cardiovasc Res. 1974 May;8(3):299–312. doi: 10.1093/cvr/8.3.299. [DOI] [PubMed] [Google Scholar]
  5. GINSBURG J. M., LOTSPEICH W. D. INTERRELATIONS OF ARSENATE AND PHOSPHATE TRANSPORT IN THE DOG KIDNEY. Am J Physiol. 1963 Oct;205:707–714. doi: 10.1152/ajplegacy.1963.205.4.707. [DOI] [PubMed] [Google Scholar]
  6. GINSBURG J. M. RENAL MECHANISM FOR EXCRETION AND TRANSFORMATION OF ARSENIC IN THE DOG. Am J Physiol. 1965 May;208:832–840. doi: 10.1152/ajplegacy.1965.208.5.832. [DOI] [PubMed] [Google Scholar]
  7. Glazener F. S., Ellis J. G., Johnson P. K. Electrocardiographic findings with arsenic poisoning. Calif Med. 1968 Aug;109(2):158–162. [PMC free article] [PubMed] [Google Scholar]
  8. Grobe V. J. Periphere Durchblutungsstörungen und Akrocyanose bei arsengeschädigten Moselwinzern. Berufsdermatosen. 1976 Jun;24(3):78–84. [PubMed] [Google Scholar]
  9. Lee A. M., Fraumeni J. F., Jr Arsenic and respiratory cancer in man: an occupational study. J Natl Cancer Inst. 1969 Jun;42(6):1045–1052. [PubMed] [Google Scholar]
  10. MASSMANN W., OPITZ H. Experimentelle Untersuchungen über Ekg-Veränderungen bei chronischer Arsenvergiftung. Z Kreislaufforsch. 1954 Oct;43(19-20):704–713. [PubMed] [Google Scholar]
  11. Moran S., Maturana G., Rosenberg H., Casanegra P., Dubernet J. Occlusions coronariennes liées à une intoxication arsenicale chronique. A propos de 2 cas opérés. Arch Mal Coeur Vaiss. 1977 Oct;70(10):1115–1120. [PubMed] [Google Scholar]
  12. Oira M., Aoyama H. [Epidemiological studies on the Morinaga powdered milk poisoning incident]. Nihon Eiseigaku Zasshi. 1973 Feb;27(6):500–531. doi: 10.1265/jjh.27.500. [DOI] [PubMed] [Google Scholar]
  13. Orheim R. M., Bovee H. H. Atomic absorption determination of nanogram quantities of arsenic in biological media. Anal Chem. 1974 Jun;46(7):921–922. doi: 10.1021/ac60343a047. [DOI] [PubMed] [Google Scholar]
  14. Pinto S. S., Henderson V., Enterline P. E. Mortality experience of arsenic-exposed workers. Arch Environ Health. 1978 Nov-Dec;33(6):325–331. doi: 10.1080/00039896.1978.10667356. [DOI] [PubMed] [Google Scholar]
  15. Rosenberg H. G. Systemic arterial disease and chronic arsenicism in infants. Arch Pathol. 1974 Jun;97(6):360–365. [PubMed] [Google Scholar]
  16. Rosenberg H. G. Systemic arterial disease with myocardial infarction. Report on two infants. Circulation. 1973 Feb;47(2):270–275. doi: 10.1161/01.cir.47.2.270. [DOI] [PubMed] [Google Scholar]
  17. Tadepalli A. S., Mills E., Schanberg S. M. Depression and enhancement of baroreceptor pressor response in cats after intracerebroventricular injection of noradrenergic blocking agents: dependence on supracollicular areas of the brain. Circ Res. 1976 Nov;39(5):724–730. doi: 10.1161/01.res.39.5.724. [DOI] [PubMed] [Google Scholar]
  18. WEINBERG S. L. The electrocardiogram in acute arsenic poisoning. Am Heart J. 1960 Dec;60:971–975. doi: 10.1016/0002-8703(60)90129-0. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Industrial Medicine are provided here courtesy of BMJ Publishing Group

RESOURCES